API Professional Cefuroxime Axetil Uti 64544 07 6 Antibiotic Treatment For Lyme Disease

Basic Information
Place of Origin: Shaanxi, China
Brand Name: Accenturebio
Certification: GMP, ISO, SGS, HALAL
Model Number: Accenture-CefuroxiMe axetil
Minimum Order Quantity: 5kg
Price: $194-$224 per kilogram
Packaging Details: 1-25kg bag, 25kg drum
Delivery Time: 1-3 work days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 5200 kg per month
Detail Information
Product Name: CefuroxiMe Axetil Cas No.: 64544-07-6
EINECS No.: 638-760-6 Appearance: White Crystalline Powder
Molecular Formula: C20H22N4O10S Application: Pharmaceutical Raw Intermediates
Usage: Animal Pharmaceuticals Certificate: HALA/ISO9001
High Light:

uti antibiotic cephalexin


clarithromycin powder

Product Description

CAS.64544-07-6 Top quality API bulk CefuroxiMe axetil antibiotic powder for lyme

CefuroxiMe axetil Introduction:

Cefuroxime is the second-generation broad-spectrum semi-synthetic cephalosporin, and it has almost all antibacterial effects on all strains that are sensitive to cefalotin and ceftazidime, and the cefuroxime acetil powder is also effective against a wide range of gram-negative bacilli including enterobacteriaceae and sputum Proteus is effective. Cefuroxime clinical treatment of respiratory tract, facial features, bone, soft tissue infections and meningitis, simple urinary tract infection clinical and bacteriological effective rate of 70% to 100%, prevention of postoperative wound infection also has a satisfactory effect.
Cefuroxime is effective in the treatment of acute gonorrhea and urinary tract infections caused by gonococcal infection. A hospital in 169 cases of gonorrhea patients, intramuscular injection of cefuroxime a single dose of 1.5g, 160 cases of intramuscular injection disappeared in 1 to 5 days, the cure rate was 97.7%, short-term and long-term bacteriological cure rate of cefuroxime 55% and 48%.

CefuroxiMe axetil Function:

The CefuroxiMe avetil powder is applicable to hemolytic streptococcus, Staphylococcus aureus (methicillin-resistant strains except), and Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, etc. caused by susceptible strains of Enterobacteriaceae adults with acute pharyngitis or tonsillitis, acute otitis media, maxillary sinusitis, acute exacerbation of chronic bronchitis, acute bronchitis, uncomplicated urinary tract infections, skin and soft tissue infections and no complications Neisseria gonorrhoeae urethritis and cervicitis. Children pharyngitis or tonsillitis, acute otitis media and impetigo, etc.

CefuroxiMe axetil Application:
Treatment of infections of lower respiratory tract including pneumonia, urinary tract, skin and skin structures, bone and joints; treatment of bacteremia/septicemia, CNS infections, intra-abdominal infections including peritonitis, gynecological infections including pelvic inflammatory disease.GMP Quality CAS 64485-93-4 99% cefuroxime axetil.
CefuroxiMe axetil Specification:
PRODUCT NAME CefuroxiMe Axetil
CAS no. 64544-07-6 Quantity 560kgs
Storage In an airtight container, protected from light.
Items of analysis Specification Results
Description White or Off-white powder Complies
Assay(C16H16N408S) 96.0%~102.0% 99.12%
Identification HPLC Complies
  IR Complies
Crystallinity No extinction position and birefringence Complies
Isomer 0.48~0.55 0.52
Isomer impurity ≤1.5% 1.2
Any impurity ≤0.5% 0.32
Total impurity ≤3.0% 1.88
Water ≤1.5% 1.23
Burning residue ≤0.2% 0.11
Heavy metal ≤20ppm <20ppm
Conclusion Conforms with enterprise standards

API Professional Cefuroxime Axetil Uti 64544 07 6 Antibiotic Treatment For Lyme Disease 0API Professional Cefuroxime Axetil Uti 64544 07 6 Antibiotic Treatment For Lyme Disease 1

Contact Details

Phone Number : 8618402999820

WhatsApp : +8618402999820